Tongjiang Series Prescription Combined With PPIs Descending Ladder Withdrawal in Treating Nonerosive Reflux Disease

NCT04340297 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Nonerosive Reflux Disease

Interventions

DRUG: Tongjiang series prescription(Tongjiang granules, Jianpi Qinghua granules and Wenpi Qingwei granules)
DRUG: Acid inhibitors
DRUG: Placebo

Sponsor

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]